Inês C. Ferreira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Inês C. Ferreira has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Cristiana A. V. Torres
Associate Laboratory i4HB—Institute for Health and Bioeconomy, School of Science and Technology, NOVA University Lisbon, 2829-516 Caparica, Portugal
2 shared publications - Filomena Freitas
UCIBIO—Applied Molecular Biosciences Unit, Department of Chemistry, School of Science and Technology, NOVA University Lisbon, 2829-516 Caparica, Portugal
2 shared publications - Luisa A. Neves
LAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, FCT NOVA, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal
2 shared publications - Carlos Alberto Mateus Afonso
Research Institute for Medicines (iMed.ULisboa) Faculty of Pharmacy Universidade de Lisboa Lisbon Portugal
1 shared publication Diana Araújo
UCIBIO‐REQUIMTE, Chemistry Department, Faculty of Sciences and Technology NOVA University of Lisbon, Caparica Campus Lisbon Portugal
1 shared publication- Gonçalo A. Marcelo
BIOSCOPE Group, LAQV@REQUIMTE, Chemistry Department, NOVA School of Science and Technology, 2829-516 Caparica, Portugal
1 shared publication
Latest Publications
- Open Access
- 30 November 2025
- Published by Wiley in Biofuels, Bioproducts and Biorefining
- Vol. 20 (2) , 691-702
Sustainable recovery of a chitin–glucan complex–protein biocomposite from yeast biomass using biocompatible ionic liquids
Chitin–glucan complex (CGC) is typically extracted from fungal or yeast biomass using harsh alkaline treatments that not only generate high‐salt, organic‐rich effluents, but also negatively impact the structural and functional properties of the recovered copolymer, while wasting the yeast protein fraction, which is discarded. In this work, we present an innovative, environmentally friendly procedure based on the use of cholinium acetate ([Cho][OAc]), a biocompatible ionic liquid (IL), as a novel solvent to directly recover a natural CGC–protein biocomposite from Komagataella pastoris cells. The process was optimized via response surface methodology, achieving an overall recovery yield exceeding 40 wt% under mild thermal conditions (82–116 °C) and moderate biomass loadings (7.5–15 wt%), with reaction time having minimal effect. Reaction at 90 °C for 24 h, from a 11 wt% yeast biomass suspension, resulted in the recovery of a CGC–protein biocomposite comprising 64 wt% CGC and 36 wt% protein, with minimal inorganic salts contamination (0.8 wt%). This represents a novel, value‐added biomaterial, leveraging the Generally Recognized as Safe status of K. pastoris and combining the bioactive properties of both CGC and yeast‐derived proteins. The developed IL‐based method offers a sustainable, safe, and efficient alternative to traditional approaches and opens new possibilities for the valorization of yeast biomass and the use of CGC–protein biocomposites in food, cosmetic, and biomedical applications.
- 30 November 2025
- Published by Wiley in Biofuels, Bioproducts and Biorefining
- Vol. 20 (2) , 691-702
Open AccessSustainable recovery of a chitin–glucan complex–protein biocomposite from yeast biomass using biocompatible ionic liquids
Chitin–glucan complex (CGC) is typically extracted from fungal or yeast biomass using harsh alkaline treatments that not only generate high‐salt, organic‐rich effluents, but also negatively impact the structural and functional properties of the recovered copolymer, while wasting the yeast protein fraction, which is discarded. In this work, we present an innovative, environmentally friendly procedure based on the use of cholinium acetate ([Cho][OAc]), a biocompatible ionic liquid (IL), as a novel solvent to directly recover a natural CGC–protein biocomposite from Komagataella pastoris cells. The process was optimized via response surface methodology, achieving an overall recovery yield exceeding 40 wt% under mild thermal conditions (82–116 °C) and moderate biomass loadings (7.5–15 wt%), with reaction time having minimal effect. Reaction at 90 °C for 24 h, from a 11 wt% yeast biomass suspension, resulted in the recovery of a CGC–protein biocomposite comprising 64 wt% CGC and 36 wt% protein, with minimal inorganic salts contamination (0.8 wt%). This represents a novel, value‐added biomaterial, leveraging the Generally Recognized as Safe status of K. pastoris and combining the bioactive properties of both CGC and yeast‐derived proteins. The developed IL‐based method offers a sustainable, safe, and efficient alternative to traditional approaches and opens new possibilities for the valorization of yeast biomass and the use of CGC–protein biocomposites in food, cosmetic, and biomedical applications.
- Open Access
- 22 December 2019
- Published by Wiley in Journal of Chemical Technology & Biotechnology
- Vol. 95 (5) , 1277-1289
Chitinous polymers: extraction from fungal sources, characterization and processing towards value‐added applications
Chitin, chitosan and their complexes with β‐glucan (chitin–glucan complex, CGC, and chitosan–glucan complex, ChGC) are value‐added polysaccharides extracted from the cell‐walls of many fungi. Commercial chitin and its deacetylated form, chitosan, are currently obtained from marine waste material, mostly animal sources (crustaceans and marine invertebrates), through harsh chemical procedures that have low reproducibility due to the variability of the composition of the sources and their seasonal character. These disadvantages are overcome by using fungi as sources of chitinous polymers. The extraction of chitin/chitosan from fungi cell‐walls has the great advantage of yielding products with stable composition and properties, using simpler procedures, with the added benefit of also generating CGC and ChGC, two copolymers that combine the proven properties of chitin/chitosan with those of β‐glucans. Over the last decades, fungal chitinous polymers have been the focus of extensive research that included optimization of the cultivation conditions of a wide range of species and the development of optimized extraction, purification and characterization techniques, as well as the demonstration of the biopolymers' biological properties, which include immunomodulatory, anticancer, antioxidant and antimicrobial activity. Given these properties, several attempts were made to develop applications for them in areas ranging from biomedicine and pharmaceuticals to food and agriculture. Despite their wide range of proven functional properties that include the ability to form different polymeric structures, as well as biological activity, fungal chitinous biopolymers are still underexplored. Nevertheless, these biopolymers hold great potential for development into valuable products or applications that are surely worth further investigation. © 2019 Society of Chemical Industry
- 22 December 2019
- Published by Wiley in Journal of Chemical Technology & Biotechnology
- Vol. 95 (5) , 1277-1289
Open AccessChitinous polymers: extraction from fungal sources, characterization and processing towards value‐added applications
Chitin, chitosan and their complexes with β‐glucan (chitin–glucan complex, CGC, and chitosan–glucan complex, ChGC) are value‐added polysaccharides extracted from the cell‐walls of many fungi. Commercial chitin and its deacetylated form, chitosan, are currently obtained from marine waste material, mostly animal sources (crustaceans and marine invertebrates), through harsh chemical procedures that have low reproducibility due to the variability of the composition of the sources and their seasonal character. These disadvantages are overcome by using fungi as sources of chitinous polymers. The extraction of chitin/chitosan from fungi cell‐walls has the great advantage of yielding products with stable composition and properties, using simpler procedures, with the added benefit of also generating CGC and ChGC, two copolymers that combine the proven properties of chitin/chitosan with those of β‐glucans. Over the last decades, fungal chitinous polymers have been the focus of extensive research that included optimization of the cultivation conditions of a wide range of species and the development of optimized extraction, purification and characterization techniques, as well as the demonstration of the biopolymers' biological properties, which include immunomodulatory, anticancer, antioxidant and antimicrobial activity. Given these properties, several attempts were made to develop applications for them in areas ranging from biomedicine and pharmaceuticals to food and agriculture. Despite their wide range of proven functional properties that include the ability to form different polymeric structures, as well as biological activity, fungal chitinous biopolymers are still underexplored. Nevertheless, these biopolymers hold great potential for development into valuable products or applications that are surely worth further investigation. © 2019 Society of Chemical Industry
- 1 May 2018
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 542 (1-2) , 125-131
Development of itaconic acid-based molecular imprinted polymers using supercritical fluid technology for pH-triggered drug delivery
- 1 May 2018
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 542 (1-2) , 125-131
Development of itaconic acid-based molecular imprinted polymers using supercritical fluid technology for pH-triggered drug delivery